Vivos Therapeutics, Inc. (NASDAQ: VVOS)

Vivos Therapeutics, Inc., a company commonly recognized by its stock symbol VVOS, operates in the medical technology industry. The company is dedicated to the development and commercialization of innovative diagnostic and multi-disciplinary treatment modalities for patients with dentofacial abnormalities and related medical conditions, such as obstructive sleep apnea (OSA) and snoring in adults.

Vivos Therapeutics primarily focuses on expanding awareness of and providing treatment options for OSA through the dental industry, which it identifies as a large and relatively untapped market for OSA treatment. The company's operations span across various countries, with a significant presence in the United States.

The revenue for Vivos Therapeutics is generated through the sale of its proprietary oral appliances, diagnostic tools, myofunctional therapy, clinical treatments, continuing education, and practice solutions. Its primary products include the DNA appliance, mRNA appliance, and mmRNA appliance, all designed to treat mild to severe OSA in adults. Additionally, the company offers a range of diagnostic technologies, such as VivoScore, Rhinomanometry, Cone Beam Computerized Tomography (CBCT), and Joint Vibration Analysis (JVA).

In a highly competitive industry, Vivos Therapeutics competes with established players like ResMed and Philips Healthcare. However, the company believes its proprietary products and treatment approach offer a unique value proposition. This proposition focuses on non-surgical, non-invasive, and low-cost alternatives to traditional treatments such as continuous positive airway pressure (CPAP) therapy.

The company's competitive advantages include its proprietary oral appliances, which have been shown to be effective in treating mild to severe OSA. Furthermore, Vivos Therapeutics' comprehensive treatment approach combines oral appliances with myofunctional therapy and other diagnostic and therapeutic modalities. Additionally, the company's focus on the dental industry and its relationships with dentists and other healthcare professionals provide a strong distribution channel and access to a large patient base.

The customers of Vivos Therapeutics include dentists, general practice physicians, sleep specialist physicians, myofunctional therapists, nutritionists, chiropractors, physical therapists, and other healthcare professionals. The company's products and services are used in a collaborative multidisciplinary treatment model, comprising dentists, general practice physicians, sleep specialist physicians, myofunctional therapists, nutritionists, chiropractors, physical therapists, and other healthcare professionals.

Among the brand names and/or trade names of its products and services are the DNA appliance, mRNA appliance, mmRNA appliance, VivoScore, Rhinomanometry, CBCT, and JVA. These products and services contribute significantly to the company's mission of providing innovative diagnostic and treatment modalities for patients with dentofacial abnormalities and related medical conditions.